StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
GSK plc
LSE:GSK.L
Sector
Location
Market Cap
USD 77.29 B
Share Price
USD 19.08
Avg Daily Volume
9,958,476
Change (1 day)
1.65%
Change (1 year)
-2.04%
Change (YTD)
13.23%
GSK plc EBT Margin for the year ending December 31, 2024: 11.08%
GSK plc EBT Margin is 11.08% for the year ending December 31, 2024, a -44.58% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
-
GSK plc EBT Margin for the year ending December 31, 2023 was 19.99%, a 4.18% change year over year.
-
GSK plc EBT Margin for the year ending December 31, 2022 was 19.19%, a 20.31% change year over year.
-
GSK plc EBT Margin for the year ending December 31, 2021 was 15.95%, a -21.93% change year over year.
-
GSK plc EBT Margin for the year ending December 31, 2020 was 20.43%, a 10.87% change year over year.
Competitors
Eli Lilly and Company
USD 789.80
LLY
+18.05
2.34%
AbbVie Inc.
USD 190.58
ABBV
+4.19
2.25%
Roche Holding AG
USD 338.90
RO.SW
+1.87
0.56%
AstraZeneca PLC
USD 140.04
AZN.L
-0.39
-0.28%
Merck & Co., Inc.
USD 82.43
MRK
+0.91
1.12%
Amgen Inc.
USD 299.02
AMGN
+6.51
2.23%
Pfizer Inc.
USD 24.61
PFE
0.00%
Gilead Sciences, Inc.
USD 109.85
GILD
+0.79
0.72%
Sanofi
USD 96.84
SAN.PA
+0.90
0.94%
Bristol-Myers Squibb Company
USD 47.17
BMY
+0.74
1.59%
Chugai Pharmaceutical Co., Ltd.
USD 46.49
4519.T
+0.50
1.10%
Regeneron Pharmaceuticals, Inc.
USD 547.93
REGN
-0.03
-0.01%
Cencora, Inc.
USD 297.83
COR
+3.18
1.08%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.00
600276.SS
+0.04
0.51%
Takeda Pharmaceutical Company Limited
USD 29.68
4502.T
+0.09
0.31%
Haleon plc
USD 4.83
HLN.L
-0.03
-0.64%
Daiichi Sankyo Company, Limited
USD 24.06
4568.T
+0.57
2.43%
Ucb S.A.
USD 197.47
UCB.BR
-0.56
-0.28%
BeOne Medicines Ltd.
USD 279.16
ONC
+9.46
3.51%
Hansoh Pharmaceutical Group Company Limited
USD 4.34
3692.HK
+0.13
3.03%
Key Data
| Date | EBT Margin | Operating Income Margin | Gross Profit Margin | EBIT Margin |
|---|
Competitors
Eli Lilly and Company
USD 789.80
LLY
+18.05
2.34%
AbbVie Inc.
USD 190.58
ABBV
+4.19
2.25%
Roche Holding AG
USD 338.90
RO.SW
+1.87
0.56%
AstraZeneca PLC
USD 140.04
AZN.L
-0.39
-0.28%
Merck & Co., Inc.
USD 82.43
MRK
+0.91
1.12%
Amgen Inc.
USD 299.02
AMGN
+6.51
2.23%
Pfizer Inc.
USD 24.61
PFE
0.00%
Gilead Sciences, Inc.
USD 109.85
GILD
+0.79
0.72%
Sanofi
USD 96.84
SAN.PA
+0.90
0.94%
Bristol-Myers Squibb Company
USD 47.17
BMY
+0.74
1.59%
Chugai Pharmaceutical Co., Ltd.
USD 46.49
4519.T
+0.50
1.10%
Regeneron Pharmaceuticals, Inc.
USD 547.93
REGN
-0.03
-0.01%
Cencora, Inc.
USD 297.83
COR
+3.18
1.08%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.00
600276.SS
+0.04
0.51%
Takeda Pharmaceutical Company Limited
USD 29.68
4502.T
+0.09
0.31%
Haleon plc
USD 4.83
HLN.L
-0.03
-0.64%
Daiichi Sankyo Company, Limited
USD 24.06
4568.T
+0.57
2.43%
Ucb S.A.
USD 197.47
UCB.BR
-0.56
-0.28%
BeOne Medicines Ltd.
USD 279.16
ONC
+9.46
3.51%
Hansoh Pharmaceutical Group Company Limited
USD 4.34
3692.HK
+0.13
3.03%